ClinVar Miner

Submissions for variant NM_001378454.1(ALMS1):c.10628C>G (p.Thr3543Ser)

gnomAD frequency: 0.00688  dbSNP: rs45501594
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 9
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Invitae RCV001079318 SCV000262122 benign Alstrom syndrome 2021-12-18 criteria provided, single submitter clinical testing
Center for Pediatric Genomic Medicine,Children's Mercy Hospital and Clinics RCV000224685 SCV000280969 likely benign not provided 2015-09-29 criteria provided, single submitter clinical testing Converted during submission to Likely benign.
GeneDx RCV000224685 SCV000531893 benign not provided 2018-07-23 criteria provided, single submitter clinical testing This variant is associated with the following publications: (PMID: 26239645, 25846608)
Personalized Diabetes Medicine Program,University of Maryland School of Medicine RCV000445553 SCV000536990 benign Monogenic diabetes 2019-02-01 criteria provided, single submitter research ACMG criteria: BP4 (six predictors plus Revel score: 0.024; not using PP3's three predictors), BA1 (1% in gnomAD European population), BS2 (15 homozygotes in gnomAD), BP1 (missense variant when mostly truncating mutations)= benign
Eurofins NTD LLC (GA) RCV000434829 SCV000705014 benign not specified 2017-01-25 criteria provided, single submitter clinical testing
Laboratory for Molecular Medicine,Mass General Brigham Personalized Medicine RCV000434829 SCV000711946 benign not specified 2017-12-14 criteria provided, single submitter clinical testing p.Thr3542Ser in exon 16 of ALMS1: This variant is not expected to have clinical significance because it has been identified in 1.03% (1297/125086) of European c hromosomes including 12 homozygotes by the Genome Aggregation Database (gnomAD,; dbSNP rs45501594).
Athena Diagnostics Inc RCV000224685 SCV000840768 benign not provided 2018-07-31 criteria provided, single submitter clinical testing
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV000434829 SCV000864099 benign not specified 2016-08-02 criteria provided, single submitter clinical testing Variant summary: The ALMS1 c.10625C>G (p.Thr3542Ser, alternative name c.10631C>G) variant involves the alteration of a non-conserved nucleotide. 4/5 in silico tools predict a benign outcome for this variant. This variant was found in 824/119494 control chromosomes (5 homozygotes), predominantly observed in the European (Non-Finnish) subpopulation at a frequency of 0.0099462 (658/66156). This frequency is about 4 to 7 times the estimated maximal expected allele frequency of a pathogenic ALMS1 variant (0.0022361) for CYMO or Alstrom Syndrom, respectively. The allele frequency in the European (Non-Finnish) subpopulation suggests that this variant is likely a benign polymorphism found primarily in the populations of European (Non-Finnish) origin. The variant has been reported in patients with clinical features of Alstrom Syndrome, but without evidence of causality (ie co-segregation or functional studies). In addition, multiple clinical diagnostic laboratories/reputable databases classified this variant as benign. Taken together, this variant is classified as benign.
Natera, Inc. RCV001079318 SCV002078979 benign Alstrom syndrome 2019-12-02 no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.